510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Nexiva Closed IV Catheter System

K032843510(k) TraditionalCleared Feb 27, 2004169-day reviewClass II21 CFR 880.5200Recalls 17

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton Dickinson Infusion Therapy Systems, Inc. · FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days

Cleared on Feb 27, 2004 after a 169-day review. The FDA summary names its predicate without a number. 1 of the 72 devices in its family, counting itself, has a Class I recall. 71 later devices descend from it. It has been recalled 17 times.

Decided
Feb 27, 2004
Review
169 days
Class
Class II
Product code
FOZ
Recalls
17
Predicates
0

71 later devices descend from it, 8 citing it directly. 1 of the 72 devices in this family, counting this one, has a Class I recall.

Descendants, by year cleared 2011: 4 descendants cleared2012: 4 descendants cleared2008: 1 descendant cleared2015: 4 descendants cleared2009: 1 descendant cleared2010: 1 descendant cleared2017: 8 descendants cleared, 1 with a Class I recall12013: 3 descendants cleared2023: 4 descendants cleared2025: 9 descendants cleared2016: 5 descendants cleared2019: 2 descendants cleared2014: 4 descendants cleared2024: 4 descendants cleared2020: 5 descendants cleared2021: 4 descendants cleared2022: 5 descendants cleared2026: 3 descendants cleared200020052010201520202025
  1. This deviceK032843 Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc. · 2004
  2. Descendant · cites it directly · 40 of its ownK102520 BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc. · 2011
  3. Descendant · 2 generations on · 19 of its ownK121073 Powerglide Midline CatheterC.R. Bard, Inc. · 2012 · Recalled
  4. Descendant · cites it directly · 15 of its ownK111236 Introcan Safety (R) 3 Closed IV Catheter 18GA X 1-3/4 (45MM) and…B.Braun Melsungen AG · 2011 · Recalled
  5. Descendant · cites it directly · 13 of its ownK111366 BD Nexiva Diffusics Closed IV Catheter SystemBecton, Dickinson and Company (BD) · 2011
  6. Descendant · 3 generations on · 12 of its ownK133856 Powerglide Midline CatheterC.R. Bard, Inc. · 2014 · Recalled

Showing 5 of 71 descendants. See all descendants

Descendants cleared per year

2008: 12009: 12010: 12011: 42012: 42013: 32014: 42015: 42016: 52017: 82019: 22020: 52021: 42022: 52023: 42024: 42025: 92026: 3
2008high 9 (2025) · low 0 (2018)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 71 · See all
  • K102520BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc. · 2011 · cites it directly40descendants
  • K121073Powerglide Midline CatheterC.R. Bard, Inc. · 2012 · 2 generations on19descendants
  • K111236Introcan Safety (R) 3 Closed IV Catheter 18GA X 1-3/4 (45MM) and 18GA X 1-1/4 (32MM) /…B.Braun Melsungen AG · 2011 · cites it directly15descendants
  • K111366BD Nexiva Diffusics Closed IV Catheter SystemBecton, Dickinson and Company (BD) · 2011 · cites it directly13descendants
  • K133856Powerglide Midline CatheterC.R. Bard, Inc. · 2014 · 3 generations on12descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K032843Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc.2004—
+1K102520BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc.2011—
+2K121073Powerglide Midline CatheterC.R. Bard, Inc.20121
+1K111236Introcan Safety (R) 3 Closed IV Catheter 18GA X 1-3/4 (45MM) and 18GA X 1-1/4…B.Braun Melsungen AG20111
+1K111366BD Nexiva Diffusics Closed IV Catheter SystemBecton, Dickinson and Company (BD)2011—
+3K133856Powerglide Midline CatheterC.R. Bard, Inc.20141

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200910
201010
201140
201240
201330
201440
201540
201650
201781
201920
202050
202140
202250
202340
202440
202590
202630
FIG. 1 — Lineage of K032843, 2004–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FOZ device

  1. #1 K243403 BD Nexiva™ Closed IV Catheter Systemscore 14.8 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—BD Saf-T-Intima IVCatheter
Named without a submission number
—
*—B. Braun Introcan Safety IVCatheter
Named without a submission number
—

What descends from it? (71)

See all 71

8 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K102520BD Nexiva Closed IV Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc.201140
K111236Introcan Safety (R) 3 Closed IV Catheter 18GA X 1-3/4 (45MM) and 18GA X 1-1/4 (32MM) /…B.Braun Melsungen AG201115
K111366BD Nexiva Diffusics Closed IV Catheter SystemBecton, Dickinson and Company (BD)201113
K151513Arrow Endurance Extended Dwell Peripheral Catheter SystemArrow Internation, Inc. (Subsidiary of Teleflex Inc.)20154
K082997Terumo Hybria Closed System Safety I.V. CatheterTerumo Medical Corp.20094
K120839Novacath Secure IV Catheter System-18GTangent Medical Technologies, Inc.20121
K111334Benelli Access DeviceVascular Solutions, Inc.20110
K073471Vantagecath Intravascular CatheterAdvantage Medical Device20080

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 23, 2018Class IIZ-0384-2019Under Investigation by firmOne lot of the specified needles is not performing as intended due to a failure in the needle tip shield/safety mechanism, which may lead to an increased risk of a contaminated needlestick injury.
Oct 19, 2009Not classifiedZ-0830-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0835-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0831-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0834-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0838-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0839-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0840-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0833-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0836-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0837-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0829-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Oct 19, 2009Not classifiedZ-0832-2010Process controlManufacturing defect may allow air entry into a central venous catheter, possibly resulting in an air embolism.
Feb 3, 2005Not classifiedZ-0584-05OtherThe Y-luer connection may crack during normal product use.
Feb 3, 2005Not classifiedZ-0585-05OtherThe Y-luer connection may crack during normal product use.
Feb 3, 2005Not classifiedZ-0586-05OtherThe Y-luer connection may crack during normal product use.
Feb 3, 2005Not classifiedZ-0587-05OtherThe Y-luer connection may crack during normal product use.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K163513Arrow Endurance Extended Dwell Peripheral Catheter SystemArrow International, Inc. (Subsidiary of Teleflex, Inc.) · 2017 · 2 generations on · ◆ in the 2017 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K102520 (Becton Dickinson Infusion Therapy Systems, Inc., 2011) has gone furthest, with 40 descendants of its own.

How does its category compare?

All FOZ devices

FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FOZ

11in 2025

2007: 62008: 92009: 92010: 32011: 62012: 132013: 42014: 92015: 102016: 92017: 92018: 12019: 82020: 102021: 42022: 82023: 92024: 62025: 112026 (partial year): 7
2007high 13 (2012) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FOZ

91in 2025

2007: 159 days median2008: 103 days median2009: 30 days median2010: 28 days median2011: 132 days median2012: 122 days median2013: 104 days median2014: 99 days median2015: 107 days median2016: 63 days median2017: 51 days median2019: 140 days median2020: 191 days median2021: 242 days median2022: 183 days median2023: 129 days median2024: 190 days median2025: 91 days median2026 (partial year): 203 days median
2007high 242 (2021) · low 28 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FOZ

4in 2023

2007: 162009: 232010: 1152013: 22014: 42016: 3, 1 Class I2017: 222018: 42019: 32020: 32021: 12022: 4, 2 Class I2023: 4, 2 Class I2026 (partial year): 2
2007high 115 (2010) · low 0 (2008)2026

Class I (5 since 2007) Class II/III not classified

Adverse event reports per year · FOZ

5,110in 2025

2007: 3742008: 4222009: 5082010: 3702011: 7862012: 5602013: 6402014: 8152015: 7292016: 9252017: 1,9662018: 3,3052019: 4,3652020: 3,7972021: 4,6742022: 4,1332023: 4,4302024: 4,7722025: 5,110
2007high 5,110 (2025) · low 370 (2010)2025

MAUDE reports naming product code FOZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007615916374
200891030422
200993023508
2010328115370
201161320786
2012131220560
201341042640
20149994815
2015101070729
20169633 (1)925
2017951221,966
20181—43,305
2019814034,365
20201019133,797
2021424214,674
202281834 (2)4,133
202391294 (2)4,430
2024619004,772
2025119105,110
202672032—

What is it indicated for?

The NexivaTM intravascular catheter is inserted into a patient's vascular system for short-term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravascularly. The needle-shielding feature and luer access port aid in the prevention of needlestick injuries. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient…

Read the full statement (113 words)

The NexivaTM intravascular catheter is inserted into a patient's vascular system for short-term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravascularly. The needle-shielding feature and luer access port aid in the prevention of needlestick injuries. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure.

The 18-24 gauge Nexiva catheters are suitable for use with power injectors rated for a maximum of 300 psi when the luer access port(s) is removed and a direct connection is made.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032843: Nexiva Closed IV Catheter System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K032843

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026